Search

A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems.

… Monday, February 3, 2014 A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems. The $6.7 million project may translate into new treatments that benefit older people and those who have received a bone marrow transplant. The initiative – called

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

… Tuesday, September 30, 2014 Summary In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer. Increasingly, scientists are findings ways to shortcut the search for new cancer therapies. In a recent

A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.

… Monday, April 11, 2022 Positron emission tomography (PET) is one of the most widely used diagnostic tools in cancer care. PET scans show the location of a tumor, usually based on increased glucose intake, a hallmark of cancer cells. Despite their effectiveness, PET scans can be hard to access in developing

Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center (CUMC). Dr. Kung formally assumes his new role as Richard J. O’Reilly, MD, steps down as Chairman after more than 30 years.

… Monday, June 20, 2016 Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, January 22, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Craig B. Thompson Named to City and State’s 2021 Health Power 100 List Craig B. Thompson, MD Craig Thompson, MD, President and CEO of MSK, has been named to the  2021  City & State’s

Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.

… Thursday, November 1, 2012 Summary Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair. Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer

Campaign — inspired by Matthew Heineman’s new documentary, ‘American Symphony,’ featuring Jon Batiste and Suleika Jaouad — aims to bridge the blood stem cell and marrow donor gap and give hope to patients in need.

… Wednesday, November 29, 2023 Campaign — Inspired by Matthew Heineman’s New Documentary, ‘American Symphony,’ Featuring Jon Batiste and Suleika Jaouad — Aims To Bridge the Blood Stem Cell and Marrow Donor Gap and Give Hope to Patients in Need Memorial Sloan Kettering Cancer Center (MSK) and  NMDP/Be The

Sloan Kettering Institute scientists are understanding more about natural killer (NK) cells, which are your allies when it comes to fighting infections and cancer.

… Tuesday, June 1, 2021 Despite a name straight from a Tarantino movie, natural killer (NK) cells are your allies when it comes to fighting infections and cancer. If T cells are like a team of specialist doctors in an emergency room, NK cells are the paramedics: They arrive first on the scene and perform

… Monday, April 6, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Charles L. Sawyers, MD, Awarded the Harrington Prize for Innovation in Medicine Charles L. Sawyers, MD Charles L. Sawyers, MD, Awarded the Harrington Prize for Innovation in Medicine

Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS) since 1987 in a variety of capacities. He formally assumes his new position as George J. Bosl, MD, steps down from his role after 18 years.

… Tuesday, November 17, 2015 Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS